Intrinsic Raises $21 Million

Intrinsic Therapeutics Inc., a Woburn, Mass.-based developer of surgical equipment for use in spinal soft tissue repair, has raised around $21 million in Series D funding, according to a regulatory filing. VentureWire reports that an “undisclosed institutional investor” led the deal, and was joined by return backers New Enterprise Associates, Spray Venture Partners and Sprout Group.